Optimized lactoferrin as a highly promising treatment for intracerebral hemorrhage: Pre-clinical experience
Authors:
- Shun-Ming TingSTShun-Ming Ting
- Guanghua SunGSGuanghua Sun
- Jaroslaw AronowskiJAJaroslaw Aronowski
- 21 May 2020
- journal article
- research article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 41 (1) , 53-66
Abstract
Intracerebral hemorrhage (ICH) is the deadliest form of stroke for which there is no effective treatment, despite an endless number of pre-clinical studies and clinical trials. The obvious therapeutic target is the neutralization of toxic products of red blood cell (RBC) lysis that lead to cytotoxicity, inflammation, and oxidative damage. We used rigorous approaches and translationally relevant experimental ICH models to show that lactoferrin-(LTF)-based monotherapy is uniquely robust in reducing brain damage after ICH. Specifically, we designed, produced, and pharmacokinetically/toxicologically characterized an optimized LTF, a fusion of human LTF and the Fc domain of human IgG (FcLTF) that has a 5.8-fold longer half-life in the circulation than native LTF. Following dose-optimization studies, we showed that FcLTF reduces neurological injury caused by ICH in aged male/female mice, and in young male Sprague Dawley (SD) and spontaneously hypertensive rats (SHR). FcLTF showed a remarkably long 24-h therapeutic window. In tissue culture systems, FcLTF protected neurons from the toxic effects of RBCs and promoted microglia toward phagocytosis of RBCs and dead neurons, documenting its pleotropic effect. Our findings indicate that FcLTF is safe and effective in reducing ICH-induced damage in animal models used in this study.Keywords
This publication has 52 references indexed in Scilit:
- Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trialThe Lancet Neurology, 2019
- Neuronal Death After Hemorrhagic Stroke In Vitro and In Vivo Shares Features of Ferroptosis and NecroptosisStroke, 2017
- Targeting secondary injury in intracerebral haemorrhage—perihaematomal oedemaNature Reviews Neurology, 2015
- Intracerebral haemorrhage: mechanisms of injury and therapeutic targetsThe Lancet Neurology, 2012
- Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibition: Robust New Target or Another Big Bust for Stroke Therapeutics?Journal of Cerebral Blood Flow & Metabolism, 2012
- Molecular Pathophysiology of Cerebral HemorrhageStroke, 2011
- Role of Iron in Brain Injury After Intraventricular HemorrhageStroke, 2011
- Deferoxamine Reduces Intracerebral Hematoma-Induced Iron Accumulation and Neuronal Death in PigletsStroke, 2009
- Effects of Deferoxamine on Intracerebral Hemorrhage-Induced Brain Injury in Aged RatsStroke, 2009
- Heme and Iron Metabolism: Role in Cerebral HemorrhageJournal of Cerebral Blood Flow & Metabolism, 2003